Gynecomastia

Epidemiology, Pathophysiology, and Management

Samar N. Rahhal, John Fuqua

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Gynecomastia, defined as a palpable disk of breast tissue in males, is a relatively common condition. It is usually benign and self-resolving, especially in neonates and pubertal boys. An imbalance in the estrogen-to-androgen ratio is believed to be the culprit in the pathophysiology of gynecomastia. An increase in estrogen or a decrease in androgen is found in most pathologic entities associated with gynecomastia, such as hypogonadism, tumors, or enzymatic defects. A thorough history and physical examination is essential in distinguishing between benign and pathologic gynecomastia, as well as in directing further workup. Treatment of gynecomastia is usually for social and cosmetic reasons, and it is unnecessary in cases where it is mild or transient. However, in persistent or severe cases, treatment may be advisable. Androgens, antiestrogens, and P450 aromatase inhibitors have all been studied, with mixed results. Surgical treatment, while invasive and likely to leave scars in severe cases, is a definitive and more effective treatment option.

Original languageEnglish
Title of host publicationCurrent Clinical Neurology
Pages189-214
Number of pages26
StatePublished - 2010
Externally publishedYes

Publication series

NameCurrent Clinical Neurology
ISSN (Print)15590585

Fingerprint

Gynecomastia
Epidemiology
Androgens
Estrogens
Aromatase Inhibitors
Estrogen Receptor Modulators
Hypogonadism
Therapeutics
Cosmetics
Physical Examination
Cicatrix
Breast
History
Newborn Infant
Neoplasms

Keywords

  • Adrenocortical tumors
  • Aromatase excess syndrome
  • Danazol
  • Estrogen-to-androgen ratio
  • Fibrous phase
  • Florid phase
  • Klinefelter syndrome
  • Tamoxifen
  • Testicular tumors

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Rahhal, S. N., & Fuqua, J. (2010). Gynecomastia: Epidemiology, Pathophysiology, and Management. In Current Clinical Neurology (pp. 189-214). (Current Clinical Neurology).

Gynecomastia : Epidemiology, Pathophysiology, and Management. / Rahhal, Samar N.; Fuqua, John.

Current Clinical Neurology. 2010. p. 189-214 (Current Clinical Neurology).

Research output: Chapter in Book/Report/Conference proceedingChapter

Rahhal, SN & Fuqua, J 2010, Gynecomastia: Epidemiology, Pathophysiology, and Management. in Current Clinical Neurology. Current Clinical Neurology, pp. 189-214.
Rahhal SN, Fuqua J. Gynecomastia: Epidemiology, Pathophysiology, and Management. In Current Clinical Neurology. 2010. p. 189-214. (Current Clinical Neurology).
Rahhal, Samar N. ; Fuqua, John. / Gynecomastia : Epidemiology, Pathophysiology, and Management. Current Clinical Neurology. 2010. pp. 189-214 (Current Clinical Neurology).
@inbook{9fea0d3382d546fb9e04cf257d19ebd0,
title = "Gynecomastia: Epidemiology, Pathophysiology, and Management",
abstract = "Gynecomastia, defined as a palpable disk of breast tissue in males, is a relatively common condition. It is usually benign and self-resolving, especially in neonates and pubertal boys. An imbalance in the estrogen-to-androgen ratio is believed to be the culprit in the pathophysiology of gynecomastia. An increase in estrogen or a decrease in androgen is found in most pathologic entities associated with gynecomastia, such as hypogonadism, tumors, or enzymatic defects. A thorough history and physical examination is essential in distinguishing between benign and pathologic gynecomastia, as well as in directing further workup. Treatment of gynecomastia is usually for social and cosmetic reasons, and it is unnecessary in cases where it is mild or transient. However, in persistent or severe cases, treatment may be advisable. Androgens, antiestrogens, and P450 aromatase inhibitors have all been studied, with mixed results. Surgical treatment, while invasive and likely to leave scars in severe cases, is a definitive and more effective treatment option.",
keywords = "Adrenocortical tumors, Aromatase excess syndrome, Danazol, Estrogen-to-androgen ratio, Fibrous phase, Florid phase, Klinefelter syndrome, Tamoxifen, Testicular tumors",
author = "Rahhal, {Samar N.} and John Fuqua",
year = "2010",
language = "English",
isbn = "9781603270335",
series = "Current Clinical Neurology",
pages = "189--214",
booktitle = "Current Clinical Neurology",

}

TY - CHAP

T1 - Gynecomastia

T2 - Epidemiology, Pathophysiology, and Management

AU - Rahhal, Samar N.

AU - Fuqua, John

PY - 2010

Y1 - 2010

N2 - Gynecomastia, defined as a palpable disk of breast tissue in males, is a relatively common condition. It is usually benign and self-resolving, especially in neonates and pubertal boys. An imbalance in the estrogen-to-androgen ratio is believed to be the culprit in the pathophysiology of gynecomastia. An increase in estrogen or a decrease in androgen is found in most pathologic entities associated with gynecomastia, such as hypogonadism, tumors, or enzymatic defects. A thorough history and physical examination is essential in distinguishing between benign and pathologic gynecomastia, as well as in directing further workup. Treatment of gynecomastia is usually for social and cosmetic reasons, and it is unnecessary in cases where it is mild or transient. However, in persistent or severe cases, treatment may be advisable. Androgens, antiestrogens, and P450 aromatase inhibitors have all been studied, with mixed results. Surgical treatment, while invasive and likely to leave scars in severe cases, is a definitive and more effective treatment option.

AB - Gynecomastia, defined as a palpable disk of breast tissue in males, is a relatively common condition. It is usually benign and self-resolving, especially in neonates and pubertal boys. An imbalance in the estrogen-to-androgen ratio is believed to be the culprit in the pathophysiology of gynecomastia. An increase in estrogen or a decrease in androgen is found in most pathologic entities associated with gynecomastia, such as hypogonadism, tumors, or enzymatic defects. A thorough history and physical examination is essential in distinguishing between benign and pathologic gynecomastia, as well as in directing further workup. Treatment of gynecomastia is usually for social and cosmetic reasons, and it is unnecessary in cases where it is mild or transient. However, in persistent or severe cases, treatment may be advisable. Androgens, antiestrogens, and P450 aromatase inhibitors have all been studied, with mixed results. Surgical treatment, while invasive and likely to leave scars in severe cases, is a definitive and more effective treatment option.

KW - Adrenocortical tumors

KW - Aromatase excess syndrome

KW - Danazol

KW - Estrogen-to-androgen ratio

KW - Fibrous phase

KW - Florid phase

KW - Klinefelter syndrome

KW - Tamoxifen

KW - Testicular tumors

UR - http://www.scopus.com/inward/record.url?scp=79953658478&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953658478&partnerID=8YFLogxK

M3 - Chapter

SN - 9781603270335

T3 - Current Clinical Neurology

SP - 189

EP - 214

BT - Current Clinical Neurology

ER -